Pharmaceutical companies are trying to prevent Medicare from negotiating discounts for drugs. Their legal challenges have been unsuccessful.

Jersey City-based Block Drug (Nasdaq: BLOCA) today said it has hired Goldman, Sachs & Co to help it review strategic alternatives. These options include strategic alliances, the sale of the company, ...

The Biden administration is expected to announce, by Sept. 1, the first 10 prescription drugs it will target in its newly authorized drug price “negotiation” regime. Under the Inflation Reduction Act ...

The pharmaceutical industry’s top lobbying group filed a lawsuit Wednesday arguing that a law enacted last year allowing Medicare to directly negotiate some prescription drug prices is ...

The U.S. Chamber of Commerce on Wednesday asked a federal judge in Ohio to block Medicare's new powers to negotiate drug prices before October 1. The Chamber argued that the negotiations violate the ...

Jan 25 (Reuters) - The leading U.S. generic drug industry group said Thursday that it is asking a court to block Illinois from enforcing a state law capping price increases for certain generic drugs.

Nina Owcharenko Schaefer is a Senior Research Fellow in The Heritage Foundation’s Richard and Helen DeVos Center for Human Flourishing. Read her research. The Biden administration is expected to ...